Introduction
Calcific aortic stenosis is a common disorder in the western world and is related to aging [1] [2] [3] . It is becoming increasingly more common with a prevalence of 3% in those aged 75 years and over [4] . Aortic valve stenosis causes a left ventricular pressure overload and a compensatory myocardial response of wall thickening and concentric hypertrophy resulting from myocardial muscle fibre thickening and sarcomerogenesis [5] .
Sarcomeres thicken in response to continued systolic stress by adding filaments in parallel but do not increase in length [6] . The increase in left ventricular mass in isolated aortic stenosis is predictive of heart failure due to systolic dysfunction regardless of the severity of the valvular obstruction [7] . In other words the compensatory response of ventricular hypertrophy may in itself lead to progression of the pathology [7] .
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Aortic valve replacement relieves the high aortic valve gradient, permits regression of the left ventricular wall hypertrophy and returns life expectancy back to normal [8, 9] . It also leads to better quality of life, better NYHA (New York Heart Association) status and decreases hospitalisation rates [10] . Surgery was denied in one third of elderly patients with severe, symptomatic AS with older age and left ventricular dysfunction being the most striking characteristics of those denied surgery [11] . The greater morbidities and higher-risk profile of the current patient cohort has lead to the development of transcatheter aortic valve implantation (TAVI) and rapid deployment valves.
The aim of this study was to assess the difference in the early rate of regression in left ventricular hypertrophy between rapid deployment valves and conventional xenograft aortic valves, since the rate and extent of regression in left ventricular hypertrophy after aortic valve replacement is an important determinant of long-term survival [12] .
Methodology
Data of our first year twenty-two consecutive Perceval sutureless valve implantations performed in a single centre was compared with a similar series of twenty-two conventional Mitroflow pericardial aortic valve replacements. The two cohorts of patients we studied were matched for per-operative risk using age and current risk assessment scores including additive and logistic Euroscore risk scoring for predicted operative mortality. Data collected included mortality and stroke rate, risk score, angiographic left venticulography data, patient demographic data, as well as crossclamp and bypass times. Patients referred for a combined aortic valve replacement and coronary artery revascularization were excluded from the study. All patients underwent procedures with identical blood cardioplegia and cardiopulmonary management protocols, and the roller-pump heart lung machines, oxygenators and tubing used were sourced from the same manufacturers throughout the study. A telephone interview was performed in order to assess changes in patients' New York Heart Association (NYHA) status.
Echocardiography
Echocardiography examination and measurements were performed pre-and post-operatively within 6 months of the operation following published guidelines from the American Society of Echocardiography and other societies [13] in order to assess the initial rate of left ventricular regression. Left ventricular ejection fraction, mean and peak AV gradients and inter-ventricular septal thickness and effective orifice area (EOA) were measured. Indexed effective orifice area (iEOA) was calculated in order to characterize the degree of patient prosthesis mismatch (PPM 
Results

Pre-operative and operative parameters
These parameters are shown in Table 1 . The Mitroflow patients were smaller and lighter, most likely due to the fact that there were more women in this group compared to the Perceval group. This resulted in a higher mass p = 0.021, higher body surface area (BSA) p = 0.045 and higher Body Mass Index (BMI) p = 0.027 in the Perceval rapid deployment group. There was also an advantageous lower cross-clamp (p = 0.001) time but not bypass time (p = 0.054) in the rapid deployment group. A binomial logistic regression model, between valve types and predictors showed that cross clamp time was an independent statistically significant variable (p = 0.003). There was no statistical difference between the two groups in the improvement in NYHA status after operation. There was one death in the Perceval group in an 82-year-old male that occurred in the fourth post-op week due to acute respiratory distress syndrome (ARDS) and multi organ failure.
Echocardiography
Results of pre-operative and post-operative echocardiographic parameters are shown in Table 2 . Mean and peak pre-to postoperative gradients decreased more in the sutureless group, p=0.039 and p=0.001 respectively. Post-operative EOA was 1.69 cm 2 and 1.26 cm 2 (p=0.001) in the sutureless and conventional groups. Similarly iEOA was 0.93 cm 2 and 0.74 cm 2 (p=0.001) in the sutureless and conventional groups. Post-operative interventricular septal thickness was 1.13 cm 2 in the sutureless and 1.35 cm 2 in the conventional groups (p=0.011). There was also a reduction in patient-prosthesis mismatch (PPM) in the sutureless group as compared to the conventional group (p<0.001) using Pibarot's criteria [14] . In the rapid deployment group, there were 82% with no mismatch and 9% each with moderate and severe mismatch. In the conventional group 54% had no mismatch, 32% had mild mismatch and 14% severe mismatch. The presence or absence of RDW between the two patient groups was statistically significant, Chi-square test p=0.026.
Discussion
An ideal prosthetic aortic valve should be quick to insert and present the lowest possible gradient. The first attribute should make aortic valve replacement (AVR) surgery safer, improving short-term results and permitting marginal, high-risk patients to be operated. The second attribute leads to a lower resistance to flow and enhances left ventricular regression and therefore improves long-term results.
Category of valves used
The Livanova Perceval S bioprosthetic valve is a surgical sutureless self-expanding valve without a sewing ring. It has a basic construction similar to the Pericarbon Freedom Stentless valve, which however requires suturing of the inflow and outflow sides. Instead the Perceval valve has an additional supra-annular aortic stent made of a super-elastic alloy. Three temporary and removable anchoring sutures allow accurate positioning of the prosthesis [15] to the nadir of the sinuses of Valsalva in the aortic root. A further important adjunct to the Perceval valve is the subannular curtain, which acts to diminish the risk of paravalvular leak as this is an important haemodynamic complication. In a population of patients implanted with TAVI valves, paravalvular leak was associated with a significant difference in mortality (25 versus 0%; p = 0.04) [16] . Its major advantage is in shortening cross clamp time [17] .
The Sorin Mitroflow valve was introduced in 1982 and is an established valve with good clinical results [18, 19] . In this pericardial valve, the leaflet hinge point is located on the outside of the strut. This is important as it leads to a larger orifice area while at the same time diminishes stresses at the hinge point as it is supported by the strut during valve closure when the pressure gradient across the valve is the highest.
Shrestha reported a cumulative life expectancy survival with Perceval valves that was worse than conventional biological valves from 2.5 years post-operatively. However in this study the sutureless group had a statistically significant higher operative risk with a logistic EuroSCORE of 20.4 ± 10.7 as compared to the conventional group at 16.7 ± 10.4 (p = 0.05) [20] . Therefore patient groups in this study were matched for operative risk order to eliminate this confounding factor.
Echocardiography
Echocardiography showed a doubling in post-operative in iEOA with Perceval sutureless valves, compared to a 33% increase in the Mitroflow conventional group. The difference in postoperative effective orifice area was probably due to the absence of a sewing ring in the Perceval valve and also because the stent exerts a radial distending force that may stretch the annulus. Though both the peak and mean gradients were lower, this did not reach statistical significance. However the differences in mean and peak pre-to post-operative gradients were greater in the sutureless group, p=0.039 and p=0.001 respectively. Our results contrast with those reported by Sepehripour that indicated that sutureless valves suffer from a higher mean valve gradient than conventional AVs [21] ; however, this paper compared sutureless valves from six papers to the conventional arm of the PARTNER Trial (transcatheter versus surgical aortic-valve replacement in high-risk patients).
The post-operative EOA was 0. conventional group. This improvement in indexed effective orifice area in the Perceval group resulted in a statistically significant reduction in PPM in the Perceval group (p<0.001), even though the patients in the Perceval group were heavier (p=0.021). This is important since PPM is associated with poorer long-term outcome due to worse haemodynamics and less regression of ventricular hypertrophy [16] . No aortic root enlargement operations are performed routinely in our centre as although aortic root enlargement may reduce trans-valvular gradients and therefore the incidence of prosthesis-patient mismatch, this has not been shown to result in an improvement in longterm clinical outcomes [22] . The advantageous increase in EOA and iEOA in the stentless Perceval group is demonstrated in the early regression in left ventricular hypertrophy by a statistically significant difference of 0.22cm in post-operative inter-ventricular septal thickness between the two groups p=0.011.
Our results compare favourably with those from other series; for example mean effective orifice area (EOA) in our series was 1.69 ± 0.44 cm 2 compared to 1.4 ± 0.4 cm 2 and 1.6 ± 0.4 cm 2 in other series. Similarly mean gradient was 13.4 ± 5.4 mmHg whilst results in published series ranged from 10 ± 5 to 14 ± 6 mmHg and peak gradient was 23.2 ± 9.9 mmHg compared to a range from 19 ± 8 to 27 ± 11 mmHg [23] .
Advantages of rapid deployment valves
Rapid deployment AVR can be considered as a substitute to conventional AVR, especially for elderly patients with intermediate to high operative risk [24] . Another use is as a replacement in stentless bioprosthesis failure [25] . Rapid deployment valves reduce complexity of conventional valve operations [26] yet permit precise reproducible positioning [15] .
Whilst the design of rapid deployment valves is similar in concept to Trans Aortic Valve Implantation (TAVI) prosthesis [27] , the surgical approach differs in that it provides direct visualization and permits excision of the aortic valve and adjacent calcifications instead of lateral compression by the TAVI stent. The decalcification of the valve is important in that it may reduce the possibility of embolic showers particularly to the brain although this remains unproven [28] . The major degree of crimping required with TAVI valves may reduce prosthesis durability [29] .
The reduction in implantation time with rapid deployment valves results in lower cross-clamp times should contribute to a reduction in postoperative complications [30, 31] . The absence of a conventional sewing ring should lead to improved haemodynamics with greater EOA and lower post-operative aortic valve gradients, particularly important in older patients with small aortic roots [20] . Sutureless valves result in a higher rate of heart block compared to conventional AVR, with approximately 10% requiring a permanent pacemaker [24] . The mortality, neurological deficit, renal failure and post-operative bleeding rates of sutureless and conventional valves are similar, but there is an increased incidence of endocarditis and paravalvular leaks [21] .
Left ventricular regression
Left ventricular hypertrophy is a dangerous consequence of the pressure load on the left ventricle resulting from aortic stenosis [32] . There is an independent relationship between indexed-EOA and the extent of regression in left ventricular mass after AVR [33] . There is lesser regression of left ventricular hypertrophy after AVR with PPM, with a smaller decrease in chamber internal dimension in patients with PPM compared to those without a mismatch [34] . In our series sutureless valve implantation resulted in a larger iEOA and a marked decrease in PPM and this would be expected to result in more complete LV regression. An enhanced LV mass regression after AVR is associated with better long-term survival [35] . We have shown that there is a statistically significant difference in the rate of early (before 6 months post-op) LV regression when a sutureless prosthesis was used, suggestive of better long-term outcomes including mortality, heart failure and decreased admission rates [10, 36] .
Limitations
This case-matched study was performed with a small number of patients. This may add biases caused by not assigning patients randomly to a treatment arm, resulting in an augmented risk of introducing confounding variables.
Conclusion
Use of sutureless valves resulted in larger EOA and iEOA, decreased PPM and lead to a statistically significant faster regression in early inter-ventricular septal thickness, indicating early left ventricular mass reduction and modelling. The rate and extent of regression in left ventricular hypertrophy after aortic valve replacement is an important determinant of longterm survival including mortality, heart failure and decreased admission rates.
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